SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-107639
Filing Date
2021-08-19
Accepted
2021-08-19 13:05:59
Documents
13
Period of Report
2021-08-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2125525d1_8k.htm   iXBRL 8-K 46491
  Complete submission text file 0001104659-21-107639.txt   325000

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA abbv-20210819.xsd EX-101.SCH 5650
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20210819_def.xml EX-101.DEF 31981
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20210819_lab.xml EX-101.LAB 46869
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20210819_pre.xml EX-101.PRE 30051
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2125525d1_8k_htm.xml XML 14538
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 211189536
SIC: 2834 Pharmaceutical Preparations